Golden, Colorado — January 26, 2023 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”),&nbs...
Golden, Colorado — January 9, 2023 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision on...
Golden, Colorado — December 6, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), the only US p...
Golden, Colorado — November 28, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision...
Golden, Colorado — November 29, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision...
Golden, Colorado — November 28, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision...
Theralink® Technologies Receives Final Medicare Reimbursement Rate Determination and PTAN Enrollment
Golden, Colorado — November 14, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision...
Golden, Colorado — July 25th, 2022 — Theralink Technologies, Inc. (OTC: THER) (“Theralink” or the “Company”), a precis...
Denver, Colorado — June 15, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision medi...
Theralink currently supports preclinical and clinical studies across 18 biopharma clients, including multinational corporations...